Distributors

Ping An Biomedical

Ping An Biomedical released FY2025 Q1 earnings on September 29 (EST), actual revenue USD 1.249 M, actual EPS USD -0.0161

Ping An Biomedical released FY2025 Q2 earnings on September 29 (EST), actual revenue USD 1.255 M, actual EPS USD -0.0161

Ping An Biomedical released FY2025 Semi-Annual Earnings on September 29 Post-Market (EST), with actual revenue of USD 2.504 M and actual EPS of USD -0.0322

Ping An Biomedical released FY2023 Q3 earnings on January 24, 2025 (EST), with actual revenue of USD 3.476 M and EPS of USD 0.0012

Ping An Biomedical released FY2024 Annual Earnings on January 24, 2025 (EST), Actual Revenue: USD 12.26 M, Actual EPS: USD -0.0099

Ping An Biomedical released FY2023 9 Months Earnings on January 24, 2025 (EST), with actual revenue of USD 8.111 M and EPS of USD -0.0093

Ping An Biomedical released FY2023 Q4 earnings on January 24 Post-Market (EST), actual revenue USD 3.461 M, actual EPS USD 0.0012

Ping An Biomedical released FY2023 earnings on January 24, 2025 (EST), with actual revenue of USD 11.63 M and EPS of USD -0.0077

Ping An Biomedical released FY2024 Q3 earnings on January 24, 2025 (EST), with actual revenue of USD 2.883 M and EPS of USD -0.0058

Ping An Biomedical released FY2024 9 Months Earnings on January 24, 2025 (EST), with actual revenue of USD 9.27 M and EPS of USD -0.0039

Ping An Biomedical released FY2024 Q4 earnings on January 24 Post-Market (EST), actual revenue USD 2.988 M, actual EPS USD -0.006

Ping An Biomedical released FY2024 Q2 earnings on October 4, 2024 (EST), with actual revenue of USD 3.166 M and EPS of USD 0.0009

Ping An Biomedical released FY2023 Q1 earnings on October 4, 2024 (EST), actual revenue USD 2.305 M, actual EPS USD -0.0052

Ping An Biomedical released FY2023 Q2 earnings on October 4, 2024 (EST) with actual revenue of USD 2.33 M and EPS of USD -0.0053

Ping An Biomedical released FY2023 Semi-Annual earnings on October 4, 2024 (EST), with actual revenue of USD 4.635 M and EPS of USD -0.0105

Ping An Biomedical released FY2024 Q1 earnings on October 4 EST, actual revenue USD 3.221 M, actual EPS USD 0.0009

Ping An Biomedical released FY2024 Semi-Annual earnings on October 4, 2024 (EST), with actual revenue of USD 6.387 M and actual EPS of USD 0.0018

Rich Sparkle

Novabay Pharmac

Valens Semiconductor

Greenpower Motor

Alpha Tech

Offerpad Solutions

VCI Global

Tryhard

Tradr 2X Long APLD Daily ETF

ZeZentalis Pharma

J-Long

Pool

大健云仓

Gold.com

Alliance ENT

Weyco

Redcloud

Brillia

Raytech

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Ping An Biomedical(PASW.US)